Cytotoxic T-lymphocyte responses against mutated P21 ras peptides: An analysis of specific T-cell receptor gene usage

International Journal of Cancer

Volumn 68, Issue 4, 1996, Pages 471-478

  Juretic, Antonio ^a   Jürgens Göbel, Jutta ^a   Schaefer, Christoph ^a   Noppen, Christoph ^a   Willimann, Thomas E ^a   Kocher, Thomas ^a   Zuder, Markus ^a   Harder, Felix ^a   Heberer, Michael ^a   Spagnoli, Giulio C ^a,b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A2 ANTIGEN; ONCOPROTEIN; PROTEIN P21; SYNTHETIC PEPTIDE; T LYMPHOCYTE RECEPTOR;

ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; BASE SEQUENCE; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; PROTO-ONCOGENE PROTEINS P21(RAS); RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 10544252274     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19961115)68:4<471::AID-IJC12>3.0.CO;2-8     Document Type: Article

References (24)

1. Bos, J.L., ras oncogenes in human cancer: a review, Cancer Res., 49, 4682-4689 (1989).
2. CERNY, A., FOWLER, P., BROTHERS, M.A., HOUGHTON, M., SCHLICHT, H. and CHISARI, F., Induction in vitro of a primary human anti-viral cytotoxic-T-cell response. Europ. J. Immunol., 25, 627-630 (1995).
3. CHEEVER, M.A., DISIS, M.L., BERNHARD, H., GRALOW, J.R., HAND, S.L., HUSEBY, E.S., QIN, H.L., TAKAHASHI, M. and CHEN, W., Immunity to oncogenic proteins. Immunol., Rev., 145, 33-59 (1995).
4. CONCANNON, P., PICKERING, L.A., KUNG, P. and HOOD, L., Diversity and structure of human T-cell-receptor β-chain variable-region genes. Proc. nat. Acad. Sci. (Wash.), 83, 6598-6602 (1986).
5. D'AMARO, J., HOUBIERS, J.G., DRIJFHOUT, J.W., BRANDT, R.M., SCHIPPER, R., BAVINCK, J.N., MELIEF, C.J. and KAST, W.M., A computer program for predicting possible cytotoxic-T-lymphocyte epitopes based on HLA-class-I-peptide-binding motifs. Hum. Immunol. 43, 13-18 (1995).
6. FOSSUM, B., BREIVIK, J., MELING, G.I., GEDDE-DAHL III, T., HANSEN, T., KNUDSEN, I., ROGNUM, T.O., THORSBY, E. and GAUDERNACK, G., A K-ras 13Gly → Asp mutation is recognized by HLA-DQ7-restricted T cells in a patient with colorectal cancer. Modifying effect of DQ7 on established cancers harbouring this mutation? Int. J. Cancer, 58, 506-511 (1994a).
7. + T cells recognize a peptide corresponding to a common mutation (13Gly → Asp). Int. J. Cancer, 56, 40-45 (1994b).
8. + T cells from a patient with colon carcinoma, specific for a mutant p21-ras-derived peptide (GLY13 → ASP), are cytotoxic towards a carcinoma cell line harbouring the same mutation. Cancer Immunol. Immunother., 40, 165-172 (1995).
9. FRANCO, A., FERRARI, C., SETTE, A. and CHISARI, F.V., Viral mutations, TCR antagonism and escape from the immune response. Curr. Opin. Immunol., 7, 524-531 (1995).
10. GEDDE-DAHE III, T., FOSSUM, B., ERIKSEN, J.A., THORSBY, E. and GAUDERNACK, G., T-cell clones specific for p21-ras-derived peptides: characterization of their fine specificity and HLA restriction. Europ. J. Immunol., 23, 754-760 (1993).
11. GJERTSEN, M.K., BAKKA, A., BREIVIK, J., SAETERDAL, I., SOLHEIM, B.G., SOREIDE, O., THORSBY, E. and GAUDERNACK, E., Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic-carcinoma patients carrying the corresponding ras mutation. Lancet, 346, 1399-1400 (1995).
12. HOUBIERS, J.G.A., NIJMAN, H.W., VAN DER BURG, S.H., DRIJFHOUT, J.W., KENEMANS, P., VAN DE VELDE, C.J.H., BRAND, A., MOMBURG, F., KAST, W.M. and MELIEF, C.J.M., In vitro induction of human cytotoxic-T-lymphocyte response against peptides of mutant and wild-type p53. Europ. J. Immunol., 23, 2072-2077 (1993).
13. PANINA-BORDIGNON, P., TAN, A., TERMIJTELEN, A., DEMOTZ, S., CORRADIN, G. and LANZAVECCHIA, A., Universal immunogenic T-cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Europ. J. Immunol., 19, 2237-2242 (1989).
14. PLEBANSKI, M., ALLSOPP, C.E.M., AIDOO, M., REYBURN, H. and HILL, A.V.S., Induction of peptide-specific primary cytotoxic-T-lymphocyte responses from human peripheral blood. Europ. J. Immunol., 25, 1783-1787 (1994).
15. +T-cell immunity to mutated ras protein in pancreatic- and colon-cancer patients. Cancer Res., 55, 2984-2987 (1995).
16. RAMMENSEE, H.-G., Chemistry of peptides associated with MHC-class-I and -class-II molecules. Curr. Opin. Immunol., 7, 85-96 (1995).
17. SALLUSTO, F. and LANZAVECCHIA, A., Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage-colony-stimulating factor plus interleukin 4 and down-regulated by tumor necrosis factor a. J. exp. Med., 179, 1109-1115 (1994).
18. SENSI, M. and PARMIANI, G., Analysis of TCR usage in human tumors: a new tool for assessing tumor-specific immune responses. Immunol. Today. 16, 588-595 (1995).
19. TAKAHASHI, M., CHEN, W., BYRD, D.R., DISIS, M.L., HUSEBY, E.S., QIN, H., MCCAHILL, L., NELSON, H., SHIMADA, H., OKUNO, K., YASUTOMI, M., PEACE, D.J. and CHEEVER, M.A., Antibodies to ras proteins in patients with colon cancer. Clin. Cancer Res., 1, 1071-1077 (1995).
20. TILLINGHAST, J.P., BEHLKE, M.A. and LOH, D.Y., Structure and diversity of the human T-cell-receptor β-chain variable-region genes. Science, 233, 879-883 (1986).
21. VAN ELSAS, A., NUMAN, H.W., VAN DER MINNE, C.E., MOURER, J.S., KAST, W.M., MELIEF, C.J.M. and SCHRIER, P.I., Induction and characterization of cytotoxic T lymphocytes recognizing a mutated p21RAS peptide presented by HLA-A*0201. Int. J. Cancer, 61, 389-396 (1995).
22. VAN ENDERT, P.M., RIGANELLI, D., GRECO, G., FLEISCHHAUER, K., SIDNEY, J., SETTE, A. and BACH, J.-F., The peptide-binding motif for the human transporter associated with antigen processing. J. exp. Med., 182, 1883-1895 (1995).
23. WENTWORTH, P.A., CELIS, E., CRIMI, C., STITELY, S., HALE, L., TSAI, V., SERRA, H.M., DEL GUERCIO, M.F., LIVINOSTONE, B., ALAZARD, D., FIKES, J., KUBO, R.T., GREY, H.M., CHESNUT, R.W., CHISARI, F.V. and SETTE, A., In vitro induction of primary, antigen-specific CTL from human peripheral-blood mononuclear cells stimulated with synthetic peptides. Mol. Immunol., 32, 603-612 (1995).
24. WÖLFEL, T., VAN PEL, A., BRICHARD, V., SCHNEIDER, J., SELIGER, B., MEYER ZUM BÜSCHENFELDE, K.-H. and BOON, T., Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Europ. J. Immunol., 24, 759-764 (1994).